Keywords: elan, biogen, initiate, phase, iii, trial, antegren

Elan and Biogen initiate Phase III trial for Antegren

Article | 07 January 2002

Print This

Ireland's Elan Corp and USA-based Biogen say they have "enrolled anddosed" the first patients in their Phase III trials of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in